ELV Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Elevance Health Inc (ELV) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The company's strong financial performance, insider buying, and positive congressional trading activity outweigh the recent minor price decline and mixed analyst sentiment. The technical indicators suggest stability, and the options data indicates bullish sentiment.
The MACD histogram is positive at 2.394 and expanding, indicating bullish momentum. RSI is neutral at 53.019, suggesting no overbought or oversold conditions. The stock is trading near its pivot point of 292.538 with support at 286.013 and resistance at 299.063, showing a stable price range.
Insider buying increased by 132.13% over the last month, indicating confidence in the company's future.
Congress members made 4 purchase transactions in the last 90 days, with no sales, showing strong institutional interest.
Financial performance in Q4 2025 showed robust growth, with revenue up 9.47% YoY, net income up 30.86% YoY, and EPS up 36.46% YoY.
Hedge funds are selling, with a 135.25% increase in selling activity over the last quarter.
Analysts have lowered price targets recently, citing conservative 2026 guidance and margin concerns.
The stock price has declined slightly (-0.62%) in the regular market and -0.42% in post-market trading.
In Q4 2025, Elevance Health reported strong financial growth: Revenue increased by 9.47% YoY to $49.75 billion, net income rose by 30.86% YoY to $547 million, and EPS grew by 36.46% YoY to 2.47. This indicates solid operational performance and profitability.
Analysts have mixed views on ELV. While some firms like JPMorgan and UBS maintain Buy or Overweight ratings with price targets above $390, others like RBC Capital and Deutsche Bank have downgraded the stock or issued Hold ratings, citing conservative guidance and margin concerns. The average price target remains significantly above the current price, suggesting potential upside.
